{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:15:50Z","timestamp":1792088150979,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00066-015-0884-5","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T11:45:23Z","timestamp":1441107923000},"page":"928-935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Metformin influences progression in diabetic glioblastoma patients","Metforminbeeinflusst die Progression bei diabetischen Glioblastompatienten"],"prefix":"10.1007","volume":"191","author":[{"given":"Sebastian","family":"Adeberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semi Ben","family":"Harrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Bostel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Koelsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"884_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109","journal-title":"Acta Neuropathol"},{"key":"884_CR2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"884_CR3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/1531-8249(199908)46:2<183::AID-ANA7>3.0.CO;2-7","volume":"46","author":"JN Scott","year":"1999","unstructured":"Scott JN, Rewcastle NB, Brasher PM et al (1999) Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46:183\u2013188","journal-title":"Ann Neurol"},{"key":"884_CR4","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jocn.2013.02.007","volume":"20","author":"KL Chaichana","year":"2013","unstructured":"Chaichana KL, Pendleton C, Chambless L et al (2013) Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. J Clin Neurosci 20:1422\u20131426","journal-title":"J Clin Neurosci"},{"key":"884_CR5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ijrobp.2014.07.027","volume":"90","author":"S Adeberg","year":"2014","unstructured":"Adeberg S, Konig L, Bostel T et al (2014) Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone. Int J Radiat Oncol Biol Phys 90:886\u2013896","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"884_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/0284186X.2012.692882","volume":"52","author":"SE Combs","year":"2013","unstructured":"Combs SE, Edler L, Rausch R, Welzel T, Wick W, Debus J (2013) Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma. Acta Oncol 52:147\u2013152","journal-title":"Acta Oncol"},{"key":"884_CR7","doi-asserted-by":"crossref","unstructured":"Adeberg S, Bostel T, Konig L, Welzel T, Debus J, Combs SE (2014) A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? Radiat Oncol 9:95","DOI":"10.1186\/1748-717X-9-95"},{"key":"884_CR8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2006.09.7816","volume":"25","author":"D Schulz-Ertner","year":"2007","unstructured":"Schulz-Ertner D, Tsujii H (2007) Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 25:953\u2013964","journal-title":"J Clin Oncol"},{"key":"884_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"884_CR10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.cdp.2006.07.003","volume":"30","author":"AP Polednak","year":"2006","unstructured":"Polednak AP (2006) Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev 30:466\u2013472","journal-title":"Cancer Detect Prev"},{"key":"884_CR11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/cncr.20071","volume":"100","author":"MA Weiser","year":"2004","unstructured":"Weiser MA, Cabanillas ME, Konopleva M et al (2004) Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone\/methotrexate-cytarabine regimen. Cancer 100:1179\u20131185","journal-title":"Cancer"},{"key":"884_CR12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.285.7.885","volume":"285","author":"R Yancik","year":"2001","unstructured":"Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885\u2013892","journal-title":"JAMA"},{"key":"884_CR13","first-page":"127","volume":"50","author":"Z Suba","year":"2006","unstructured":"Suba Z, Ujpal M (2006) [Correlations of insulin resistance and neoplasms]. Magy Onkol 50:127\u2013135","journal-title":"Magy Onkol"},{"key":"884_CR14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2337\/diacare.28.1.228","volume":"28","author":"Z Suba","year":"2005","unstructured":"Suba Z, Barabas J, Szabo G, Takacs D, Ujpal M (2005) Increased prevalence of diabetes and obesity in patients with salivary gland tumors. Diabetes Care 28:228","journal-title":"Diabetes Care"},{"key":"884_CR15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1054\/bjoc.2000.1582","volume":"84","author":"TI Nilsen","year":"2001","unstructured":"Nilsen TI, Vatten LJ (2001) Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 84:417\u2013422","journal-title":"Br J Cancer"},{"key":"884_CR16","first-page":"385","volume":"11","author":"LA Colangelo","year":"2002","unstructured":"Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 11:385\u2013391","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"884_CR17","doi-asserted-by":"crossref","unstructured":"Krinsley JS (2004) Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79:992\u20131000","DOI":"10.4065\/79.8.992"},{"key":"884_CR18","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G Berghe van den","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359\u20131367","journal-title":"N Engl J Med"},{"key":"884_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1227\/01.neu.0000279729.36392.42","volume":"61","author":"GF Woodworth","year":"2007","unstructured":"Woodworth GF, Chaichana KL, McGirt MJ et al (2007) Predictors of ambulatory function after surgical resection of intramedullary spinal cord tumors. Neurosurgery 61:99\u2013105. (discussion -6)","journal-title":"Neurosurgery"},{"key":"884_CR20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2217\/cns.13.12","volume":"2","author":"MR Welch","year":"2013","unstructured":"Welch MR, Grommes C (2013) Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients. CNS Oncol 2:237\u2013246","journal-title":"CNS Oncol"},{"key":"884_CR21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science 123:309\u2013314","journal-title":"Science"},{"key":"884_CR22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519\u2013530","journal-title":"J Gen Physiol"},{"key":"884_CR23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4161\/cc.9.2.10540","volume":"9","author":"D Guo","year":"2010","unstructured":"Guo D, Cloughesy TF, Radu CG, Mischel PS (2010) AMPK: a metabolic checkpoint that regulates the growth of EGFR activated glioblastomas. Cell Cycle 9:211\u2013212","journal-title":"Cell Cycle"},{"key":"884_CR24","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","volume":"46","author":"M Jalving","year":"2010","unstructured":"Jalving M, Gietema JA, Lefrandt JD et al (2010) Metformin: taking away the candy for cancer? Eur J Cancer 46:2369\u20132380","journal-title":"Eur J Cancer"},{"key":"884_CR25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1541-7786.MCR-05-0061","volume":"4","author":"N Jelluma","year":"2006","unstructured":"Jelluma N, Yang X, Stokoe D, Evan GI, Dansen TB, Haas-Kogan DA (2006) Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes. Mol Cancer Res 4:319\u2013330","journal-title":"Mol Cancer Res"},{"key":"884_CR26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hed.23409","volume":"36","author":"VC Sandulache","year":"2014","unstructured":"Sandulache VC, Hamblin JS, Skinner HD, Kubik MW, Myers JN, Zevallos JP (2014) Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma. Head Neck 36:1039\u20131043","journal-title":"Head Neck"},{"key":"884_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cam4.54","volume":"2","author":"HD Skinner","year":"2013","unstructured":"Skinner HD, Crane CH, Garrett CR et al (2013) Metformin use and improved response to therapy in rectal cancer. Cancer Med 2:99\u2013107","journal-title":"Cancer Med"},{"key":"884_CR28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3109\/0284186X.2012.718096","volume":"52","author":"HD Skinner","year":"2013","unstructured":"Skinner HD, McCurdy MR, Echeverria AE et al (2013) Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncol 52:1002\u20131009","journal-title":"Acta Oncol"},{"key":"884_CR29","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/bjc.2013.187","volume":"108","author":"Y Storozhuk","year":"2013","unstructured":"Storozhuk Y, Hopmans SN, Sanli T et al (2013) Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. Br J Cancer 108:2021\u20132032","journal-title":"Br J Cancer"},{"key":"884_CR30","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3892\/or.2014.3151","volume":"31","author":"S Ling","year":"2014","unstructured":"Ling S, Feng T, Ke Q et al (2014) Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines. Oncol Rep 31:2611\u20132618","journal-title":"Oncol Rep"},{"key":"884_CR31","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.3892\/or.2014.3485","volume":"32","author":"H Li","year":"2014","unstructured":"Li H, Chen X, Yu Y et al (2014) Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway. Oncol Rep 32:2596\u20132604","journal-title":"Oncol Rep"},{"key":"884_CR32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1593\/tlo.13556","volume":"6","author":"A Mohammed","year":"2013","unstructured":"Mohammed A, Janakiram NB, Brewer M et al (2013) Antidiabetic drug metformin prevents progression of pancreatic cancer by targeting in part cancer stem cells and mTOR signaling. Transl Oncol 6:649\u2013659","journal-title":"Transl Oncol"},{"key":"884_CR33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender A, Selvaraj A, Kim SY et al (2010) Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab 11:390\u2013401","journal-title":"Cell Metab"},{"key":"884_CR34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphys.2014.00357","volume":"5","author":"E Rozengurt","year":"2014","unstructured":"Rozengurt E (2014) Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin\/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells. Front Physiol 5:357","journal-title":"Front Physiol"},{"key":"884_CR35","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00018-007-7080-4","volume":"64","author":"A Isakovic","year":"2007","unstructured":"Isakovic A, Harhaji L, Stevanovic D et al (2007) Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell Mol Life Sci 64:1290\u20131302","journal-title":"Cell Mol Life Sci"},{"key":"884_CR36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1750-3639.2008.00179.x","volume":"18","author":"BW Scheithauer","year":"2008","unstructured":"Scheithauer BW, Fuller GN, VandenBerg SR (2008) The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathol 18:307\u2013316","journal-title":"Brain Pathol"},{"key":"884_CR37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB et al (2009) Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32:193\u2013203","journal-title":"Diabetes Care"},{"key":"884_CR38","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972","journal-title":"J Clin Oncol"},{"key":"884_CR39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3171\/jns.1999.90.1.0072","volume":"90","author":"DC Shrieve","year":"1999","unstructured":"Shrieve DC, Alexander E 3rd, Black PM et al (1999) Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90:72\u201377","journal-title":"J Neurosurg"},{"key":"884_CR40","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2005.04.5963","volume":"24","author":"RO Mirimanoff","year":"2006","unstructured":"Mirimanoff RO, Gorlia T, Mason W et al (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981\/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24:2563\u20132569","journal-title":"J Clin Oncol"},{"key":"884_CR41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00066-014-0696-z","volume":"19","author":"A Mayer","year":"2014","unstructured":"Mayer A, Vaupel P, Struss HG, Giese A, Stockinger M, Schmidberger H (2014) Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme. Strahlenther Onkol 19:933\u2013938","journal-title":"Strahlenther Onkol"},{"key":"884_CR42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1227\/01.NEU.0000315282.61035.48","volume":"63","author":"MJ McGirt","year":"2008","unstructured":"McGirt MJ, Chaichana KL, Gathinji M et al (2008) Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas. Neurosurgery 63:286\u2013291. (discussion 91)","journal-title":"Neurosurgery"},{"key":"884_CR43","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1200\/JCO.2008.19.1098","volume":"27","author":"RL Derr","year":"2009","unstructured":"Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA (2009) Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol 27:1082\u20131086","journal-title":"J Clin Oncol"},{"key":"884_CR44","doi-asserted-by":"crossref","unstructured":"Adeberg S, Bernhardt D, Foerster R, Bostel T, Koerber SA, Mohr A, Koelsche C, Rieken S, Debus J (2015) The influence of hyperglycemia during radiotherapy on survival in patients with primary glioblastoma. Acta Oncol 20:1-7","DOI":"10.3109\/0284186X.2015.1043397"},{"key":"884_CR45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/bjc.1996.446","volume":"74","author":"S Oudard","year":"1996","unstructured":"Oudard S, Arvelo F, Miccoli L et al (1996) High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss. Br J Cancer 74:839\u2013845","journal-title":"Br J Cancer"},{"key":"884_CR46","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/iju.12530","volume":"21","author":"T Kwon","year":"2014","unstructured":"Kwon T, Jeong IG, You D et al (2014) Obesity and prognosis in muscle-invasive bladder cancer: the continuing controversy. Int J Urol 21:1106\u20131112","journal-title":"Int J Urol"},{"key":"884_CR47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/107327481001700107","volume":"17","author":"EM Siegel","year":"2010","unstructured":"Siegel EM, Ulrich CM, Poole EM, Holmes RS, Jacobsen PB, Shibata D (2010) The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control 17:52\u201357","journal-title":"Cancer Control"},{"key":"884_CR48","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1200\/JCO.2010.31.0672","volume":"28","author":"HW Daniell","year":"2010","unstructured":"Daniell HW (2010) Smoking, obesity, and statin therapy in the prognosis of prostate cancer. J Clin Oncol 28:e643. (author reply e5\u20136)","journal-title":"J Clin Oncol"},{"key":"884_CR49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/JCO.2010.32.1752","volume":"29","author":"FA Sinicrope","year":"2011","unstructured":"Sinicrope FA, Dannenberg AJ (2011) Obesity and breast cancer prognosis: weight of the evidence. J Clin Oncol 29:4\u20137","journal-title":"J Clin Oncol"},{"key":"884_CR50","doi-asserted-by":"crossref","first-page":"896","DOI":"10.18632\/oncotarget.387","volume":"2","author":"S Del Barco","year":"2011","unstructured":"Del Barco S, Vazquez-Martin A, Cufi S et al (2011) Metformin: multi-faceted protection against cancer. Oncotarget 2:896\u2013917","journal-title":"Oncotarget"},{"key":"884_CR51","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1016\/S1262-3636(03)72785-2","volume":"29","author":"R Giannarelli","year":"2003","unstructured":"Giannarelli R, Aragona M, Coppelli A, Del Prato S (2003) Reducing insulin resistance with metformin: the evidence today. Diabetes Metab 29:6S28\u20136S35","journal-title":"Diabetes Metab"},{"key":"884_CR52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5966\/sctm.2012-0058","volume":"1","author":"A Sato","year":"2012","unstructured":"Sato A, Sunayama J, Okada M, et al (2012) Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK. Stem cells Transl Med 1:811\u2013824","journal-title":"Stem cells Transl Med"},{"key":"884_CR53","first-page":"282","volume":"16","author":"O Soritau","year":"2011","unstructured":"Soritau O, Tomuleasa C, Aldea M et al (2011) Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas. J BUON 16:282\u2013289","journal-title":"J BUON"},{"key":"884_CR54","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3892\/ol.2012.843","volume":"4","author":"R Ferla","year":"2012","unstructured":"Ferla R, Haspinger E, Surmacz E (2012) Metformin inhibits leptin-induced growth and migration of glioblastoma cells. Oncol Lett 4:1077\u20131081","journal-title":"Oncol Lett"},{"key":"884_CR55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/ecp.11.1","volume":"4","author":"J Dietrich","year":"2011","unstructured":"Dietrich J, Rao K, Pastorino S, Kesari S (2011) Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol 4:233\u2013242","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-015-0884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-015-0884-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-015-0884-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T02:00:04Z","timestamp":1567130404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-015-0884-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["884"],"URL":"https:\/\/doi.org\/10.1007\/s00066-015-0884-5","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}